檢索結果 - Anna A. Alekseeva

Refine Results
  1. 1

    INTRODUCTION OF COMPLEMENTARY FOODS AND FOOD ALLERGIES: NEW STUDIES AND MODERN CLINICAL GUIDELINES Leyla S. Namazova-Baranova, Elena A. Vishneva, Liliia R. Selimzianova, Svetlana G. Makarova, Anna A. Alekseeva

    出版 2017-07-01

    The article is devoted  to the issues  of introducing  complementary  foods  as prevention  of atopy  and diet therapy in children with food allergy. Food sensibilization,  as a rule, is the initial link of allergy manifestations.  It represents  the first step of the so-called atopic  march,  follo...

    全面介紹

    獲取全文
    Article
  2. 2

    Clinical Cases: Diagnostic Errors of Mastocytosis Cutaneous Forms in Children Lianna K. Aslamazyan, Kamilla E. Efendieva, Anna A. Alekseeva, Julia G. Levina, Alina R. Pankova

    出版 2022-07-01

    Background. Mastocytosis refers to the group of rare diseases with pathological mast cells accumulation in tissues. Although diagnosis of cutaneous mastocytosis is not usually difficult for experienced physicians, misdiagnosis is possible.Clinical cases description. The authors describe two clinical...

    全面介紹

    獲取全文
    Article
  3. 3

    Correction of the skin microbiome dysbiosis as an integral part of causative treatment of atopic dermatitis Yuliya G. Levina, Anna A. Alekseeva, Kamilla E. Efendiyeva, Elena A. Vishneva, Leyla S. Namazova-Baranova

    出版 2019-06-01

    The review details the role of the skin microbiome dysbiosis in the pathogenesis of atopic dermatitis. Changes in the normal microbiota of the skin with massive colonization with Staphylococcus aureus may play a key role in the disease. Studies have shown that commensal bacteria (for example, Staphy...

    全面介紹

    獲取全文
    Article
  4. 4

    The Role of Topical Glucocorticosteroid Methylprednisolone Aceponate in External Therapy of Atopic Dermatitis in Children Yuliya G. Levina, Anna A. Alekseeva, Elena A. Vishneva, Kamilla E. Efendieva, Elena A. Dobrynina

    出版 2018-01-01

    The article describes the main characteristics of local glucocorticosteroids (GCS) which are the «gold standard» for external therapy of atopic dermatitis allowing to achieve control over  the disease quickly and effectively. Methylprednisolone aceponate 0.1%  — non-fluorinated local GCS, the drug w...

    全面介紹

    獲取全文
    Article
  5. 5

    Role of Calcineurin Inhibitors in the Management of Atopic Dermatitis in Children Kamilla E. Efendieva, Leyla S. Namazova-Baranova, Juliya G. Levina, Vera G. Kalugina, Anna A. Alekseeva, Elena A. Vishneva, Konstantin S. Volkov

    出版 2023-12-01

    Atopic dermatitis (AD) is a widespread chronic inflammatory skin disease that has a significant impact on various aspects of patient's life. This review presents modern view on AD pathophysiology, its correlation with other concomitant diseases, and covers practical aspects of external anti-inf...

    全面介紹

    獲取全文
    Article
  6. 6

    New Opportunities of Dupilumab in Achieving Disease Control in Preschool Age Patients with Atopic Dermatitis: Clinical Case Julia G. Levina, Polina A. Pyzhyanova, Vera G. Kalugina, Kamilla E. Efendieva, Elena A. Vishneva, Anna A. Alekseeva, Leyla S. Namazova-Baranova

    出版 2024-09-01

    Background. Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases in children. It manifests during the first year of life in majority of cases. Early AD manifestation is a risk factor for the development of other atopic spectrum diseases in the future. Nowadays, the abi...

    全面介紹

    獲取全文
    Article
  7. 7

    Modern Possibilities of Chronic Urticaria Therapy in Children Leyla S. Namazova-Baranova, Elena A. Vishneva, Vera G. Kalugina, Anna A. Alekseeva, Yuliya G. Levina, Elena A. Dobrynina, Kamilla E. Efendieva, Konstantin S. Volkov

    出版 2018-07-01

    Chronic urticaria in children is one of the diseases that are underestimated in their severity and impact on the quality of life. The world academic literature data gives very little information on epidemiology, etiology of chronic urticaria, and researches on application of various therapies in chi...

    全面介紹

    獲取全文
    Article
  8. 8

    Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab Leyla S. Namazova-Baranova, Elena A. Vishnеva, Elena A. Dobrynina, Irina V. Vinyarskaya, Anna A. Alekseeva, Vladislav V. Chernikov, Lilia R. Selimsianova

    出版 2017-12-01

    Background. Quality of life (QoL) is an important parameter that provides additional information about changes in health status. Objective. Our aim was to study the change in QoL of patients with severe persistent bronchial asthma (BA) during the treatment with genetically engineered biological prep...

    全面介紹

    獲取全文
    Article
  9. 9

    The Prevalence of Sensitization to Food Allergens from the Group of “Big Eight” in Children with Atopic Phenotype: Cross-Sectional Study Kamilla E. Efendieva, Julia G. Levina, Vera G. Kalugina, Elena A. Vishneva, Anna A. Alekseeva, Konstantin S. Volkov, Pavel A. Levin, Leyla S. Namazova-Baranova

    出版 2024-11-01

    Background. Food allergy (FA) is a common chronic disease. There are no official data on the prevalence of FA in Russia. The results of only a few Russian studies of FA and anaphylaxis in children have been published.The aim of the study is to study the prevalence of sensitization to food allergens...

    全面介紹

    獲取全文
    Article
  10. 10

    Allergic Reactions at Enzyme Replacement Therapy in Children with Mucopolysaccharidosis Type II Julia G. Levina, Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Elena A. Vishneva, Natalia V. Zhurkova, Kamilla E. Efendieva, Anna A. Alekseeva, Vera G. Kalugina

    出版 2021-12-01

    Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is rare hereditary disease caused by changes in the IDS gene and associated deficiency of lysosomal enzyme iduronate-2-sulfatase (I2S). The main treatment scheme for children with MPS II is enzyme replacement therapy (ERT) with recombinant huma...

    全面介紹

    獲取全文
    Article
  11. 11

    Identification of Pollen and Food Sensitization Prevalence in Children with Different Atopic Phenotype Variants (Intermediate Study Results) Julia G. Levina, Vera G. Kalugina, Leyla S. Namazova-Baranova, Elena A. Vishneva, Konstantin S. Volkov, Kamilla E. Efendieva, Anna A. Alekseeva, Elena V. Kaytukovа

    出版 2023-01-01

    Background. Identification of the prevalence of pollen and food allergen molecules sensitization in children (considering regional characteristics) is relevant and crucial for personalized preventive and treatment measures development. Objective. The aim of the study is — study the prevalence of pol...

    全面介紹

    獲取全文
    Article
  12. 12

    Actual Surveillance of Children with Bronchial Asthma Elena A. Vishneva, Leyla S. Namazova-Baranova, Anna A. Alekseeva, Gennadii A. Novik, Kamilla E. Efendieva, Julia G. Levina, Elena A. Dobrynina, Liliya R. Selimzyanova

    出版 2018-01-01

    The article is devoted to the problem of timely diagnosis and current principles of management of children with bronchial asthma. Given the  increase in the prevalence of allergic pathology stated over the past  decades, the issues of differential diagnosis, integrated approach to the  treatment and...

    全面介紹

    獲取全文
    Article
  13. 13

    Modern approaches to the management of urticaria in children Alexander A. Baranov, Leyla S. Namazova-Baranova, Rakhim M. Khaitov, Nataliya I. Il’ina, Elena A. Vishneva, Anna A. Alekseeva, Vera G. Kalugina, Liliya R. Selimzyanova

    出版 2019-06-01

    The authors presented the main provisions of the current clinical guidelines for the treatment of children with urticaria. The specifics of disease epidemiolog y, etiolog y and pathogenesis are described. The steps of dif ferential diagnosis are highlighted. For pediatric patients, treatment recomme...

    全面介紹

    獲取全文
    Article
  14. 14

    Pilot Project «All-Russian Registry of Patients with Severe Bronchial Asthma.» The First Results in a Children’s Group of Patients (Moscow’s Observation Program) Leyla S. Namazova-Baranova, Elena A. Vishneva, Elena Dobrynina, Anna A. Alekseeva, Andrey S. Belevskiy, Nataliya I. Ilyina, Nadezhda P. Knyazheskaya, Olga M. Kurbacheva, Galina L. Osipova

    出版 2017-08-01

    The article presents the first results of the pilot observation program «The All-Russian Severe Asthma Patient Registry» which was started in Moscow. Objectives. The objective of this initiative is the accumulation of clinical data on patients with severe bronchial asthma in the Russian Federation....

    全面介紹

    獲取全文
    Article
  15. 15

    Modern Approaches to Achieving Control over Common Health Disorders in Infants: the Effectiveness of Extensively Hydrolyzed and Amino Acid Formulas Elena A. Vishneva, Darya S. Chemakina, Yulia G. Levina, Kamilla E. Efendieva, Vera G. Kalugina, Anna A. Alekseeva, Liliya R. Selimzyanova, Elena V. Kaitukova, Vladimir A. Barannik

    出版 2024-11-01

    Proper nutrition of the mother and baby is the most important condition for the development and health of the child. It is the first 1000 days of a child’s life that are critical for neuroontogenesis, the formation of further abilities to acquire and improve various skills, and to learn successfully...

    全面介紹

    獲取全文
    Article
  16. 16

    The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry Elena A. Vishneva, Leyla S. Namazova-Baranova, Elena A. Dobrynina, Anna A. Alekseeva, Vladimir I. Smirnov, Julia G. Levina, Vera G. Kalugina, Kamilla E. Efendieva, Konstantin S. Volkov

    出版 2018-05-01

    Background: Patient registries help to obtain relevant information about the peculiarities of certain diseases, as well as the safety and effectiveness of different medical technologies. Moreover, it allows conducting a continuous monitoring in a studied group. Objective: to analyze the effectivenes...

    全面介紹

    獲取全文
    Article
  17. 17

    Multidisciplinary Approach in Vaccination of a Child with Food Allergy: Clinical Case Vera G. Kalugina, Marina V. Fedoseenko, Anna A. Alekseeva, Kamilla E. Efendieva, Julia G. Levina, Tatiana A. Kaliuzhnaia, Svetlana V. Tolstova, Elena A. Vishneva, Leyla S. Namazova-Baranova

    出版 2022-03-01

    Children with chicken egg protein allergy are denied performing vaccination against measles, mumps, influenza in Russian Federation thus far, thus it is unreasonable. This article presents a clinical case of 2 years 6 months old boy with cow’s milk protein allergy symptoms and high levels of specifi...

    全面介紹

    獲取全文
    Article
  18. 18

    Innovative Management Methods for Patients Allergic to Cats Leyla S. Namazova-Baranova, Kamilla Y. Efendieva, Julia G. Levina, Elena A. Vishneva, Anna A. Alekseeva, Vera G. Kalugina, Konstantin S. Volkov, Polina S. Arimova, Alina R. Pankova, Anastasiya D. Lamasova

    出版 2020-09-01

    The prevalence of allergies to domestic animals increases due to the increase in the number of pets worldwide, followed by serious medical and social problems. Domestic cat (Felis domesticus) is one of the most common pets and one of the most frequent (after dust mite) source of indoor allergens and...

    全面介紹

    獲取全文
    Article
  19. 19

    Allergic Rhinitis in Children: Principles of Early Diagnosis and Effective Therapy. Overview of Clinical Recommendations Alexander A. Baranov, Leyla S. Namazova-Baranova, Rakhim M. Khaitov, Nataliya I. Ilyina, Oksana M. Kurbacheva, Gennadii A. Novik, Fedor I. Petrovsky, Elena A. Vishneva, Anna A. Alekseeva, Liliya R. Selimzyanova

    出版 2017-10-01

    The article briefly summarizes the key provisions of the clinical recommendations on medical care delivery for children with allergic rhinitis: modern approaches to diagnosis and therapy. The current document was developed by the professional association of pediatric specialists —the Union of Pediat...

    全面介紹

    獲取全文
    Article
  20. 20

    Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II Julia G. Levina, Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Elena A. Vishneva, Mariya S. Karaseva, Natalia V. Zhurkova, Kamilla E. Efendieva, Anna A. Alekseeva, Vera G. Kalugina, Artur V. Zaz’yan

    出版 2022-07-01

    Background. Enzyme replacement therapy (ERT) with iduronate-2-sulfatase recombinant forms (idursulfase and idursulfase beta) is effective for the management of mucopolysaccharidosis type II (MPS II). Patients with Hunter syndrome require lifelong ERT that can negate endogenous enzyme deficiency. How...

    全面介紹

    獲取全文
    Article